MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 109 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,548,853 | +16.1% | 601,038 | +7.8% | 0.05% | +12.2% |
| Q1 2023 | $13,389,661 | +102.2% | 557,438 | +64.2% | 0.04% | +78.3% |
| Q4 2022 | $6,620,445 | +96.0% | 339,510 | +121.3% | 0.02% | +76.9% |
| Q1 2022 | $3,378,000 | -32.7% | 153,389 | -51.3% | 0.01% | -35.0% |
| Q4 2021 | $5,022,000 | +74.6% | 314,843 | +118.0% | 0.02% | +53.8% |
| Q3 2021 | $2,876,000 | +784.9% | 144,400 | +668.1% | 0.01% | +1200.0% |
| Q2 2021 | $325,000 | +228.3% | 18,800 | +276.0% | 0.00% | – |
| Q1 2021 | $99,000 | -94.8% | 5,000 | -94.9% | 0.00% | -100.0% |
| Q2 2020 | $1,896,000 | – | 97,415 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |